BACKGROUND: A minimally invasive approach to primary hyperparathyroidism is equivalent to bilateral exploration when intraoperative parathyroid hormone (IOPTH) monitoring is used. The optimal strategy for the monitoring has been debated. HYPOTHESIS: There exists an optimal strategy for IOPTH monitoring. DESIGN: Retrospective study. SETTING: Tertiary referral hospital. PATIENTS AND METHODS: A total of 1882 patients underwent parathyroidectomy for primary hyperparathyroidism with IOPTH monitoring. Successful exploration was defined as a 50% or more decline in IOPTH level from baseline and a normal or near-normal IOPTH level at 10 minutes postexcision. These results were compared with those of alternative strategies for IOPTH monitoring, including a 50% decline at 10 minutes, 50% decline at 5 minutes, and normal IOPTH levels at 10 minutes, using the preoperative parathyroid level as baseline. RESULTS: A curative operation was performed in 1830 patients (97.2%). The current strategy had a sensitivity of 96% and an accuracy of 95%. Multiglandular disease was present in 271 patients (14.5%); 134 of 1858 patients (7.2%) whose outcomes failed to reach curative criteria had confirmed multiglandular disease. Using only a 50% decline from baseline as the curative criterion would result in a failed operation in 22.4% of patients with multiglandular disease. A 50% decline at 10 minutes was 96% sensitive and 94% accurate. A 5-minute value was 79% sensitive and 80% accurate. With use of the 5-minute value, unnecessary bilateral exploration would have been performed in 272 of 1460 patients (18.6%) compared with 62 of 1750 patients (3.5%) when using a 10-minute value. A normal 10-minute value is 91% sensitive and 90% accurate. CONCLUSIONS: A 10-minute postexcision IOPTH level that decreased 50% from baseline and is normal or near normal is highly successful. Relying on a 50% decrease alone increases the rate of operative failure in patients with multiglandular disease.
BACKGROUND: A minimally invasive approach to primary hyperparathyroidism is equivalent to bilateral exploration when intraoperative parathyroid hormone (IOPTH) monitoring is used. The optimal strategy for the monitoring has been debated. HYPOTHESIS: There exists an optimal strategy for IOPTH monitoring. DESIGN: Retrospective study. SETTING: Tertiary referral hospital. PATIENTS AND METHODS: A total of 1882 patients underwent parathyroidectomy for primary hyperparathyroidism with IOPTH monitoring. Successful exploration was defined as a 50% or more decline in IOPTH level from baseline and a normal or near-normal IOPTH level at 10 minutes postexcision. These results were compared with those of alternative strategies for IOPTH monitoring, including a 50% decline at 10 minutes, 50% decline at 5 minutes, and normal IOPTH levels at 10 minutes, using the preoperative parathyroid level as baseline. RESULTS: A curative operation was performed in 1830 patients (97.2%). The current strategy had a sensitivity of 96% and an accuracy of 95%. Multiglandular disease was present in 271 patients (14.5%); 134 of 1858 patients (7.2%) whose outcomes failed to reach curative criteria had confirmed multiglandular disease. Using only a 50% decline from baseline as the curative criterion would result in a failed operation in 22.4% of patients with multiglandular disease. A 50% decline at 10 minutes was 96% sensitive and 94% accurate. A 5-minute value was 79% sensitive and 80% accurate. With use of the 5-minute value, unnecessary bilateral exploration would have been performed in 272 of 1460 patients (18.6%) compared with 62 of 1750 patients (3.5%) when using a 10-minute value. A normal 10-minute value is 91% sensitive and 90% accurate. CONCLUSIONS: A 10-minute postexcision IOPTH level that decreased 50% from baseline and is normal or near normal is highly successful. Relying on a 50% decrease alone increases the rate of operative failure in patients with multiglandular disease.
Authors: Lauren E Orr; Travis J McKenzie; Geoffrey B Thompson; David R Farley; Robert A Wermers; Melanie L Lyden Journal: World J Surg Date: 2018-02 Impact factor: 3.352
Authors: Kelly L McCoy; Naomi H Chen; Michaele J Armstrong; Gina M Howell; Michael T Stang; Linwah Yip; Sally E Carty Journal: World J Surg Date: 2014-06 Impact factor: 3.352
Authors: Alison F Ward; Timothy Lee; Jennifer B Ogilvie; Kepal N Patel; Karen Hiotis; Costas Bizekis; Michael Zervos Journal: J Robot Surg Date: 2016-10-22
Authors: Laura I Wharry; Linwah Yip; Michaele J Armstrong; Mohamed A Virji; Michael T Stang; Sally E Carty; Kelly L McCoy Journal: World J Surg Date: 2014-03 Impact factor: 3.352
Authors: Philipp Riss; Christoph Krall; Christian Scheuba; Christian Bieglmayer; Bruno Niederle Journal: Langenbecks Arch Surg Date: 2013-07-05 Impact factor: 3.445
Authors: Andrew J Leiker; Tina W F Yen; Dan C Eastwood; Kara M Doffek; Aniko Szabo; Douglas B Evans; Tracy S Wang Journal: JAMA Surg Date: 2013-07 Impact factor: 14.766
Authors: Grace S Lee; Travis J McKenzie; Brian P Mullan; David R Farley; Geoffrey B Thompson; Melanie L Richards Journal: World J Surg Date: 2016-03 Impact factor: 3.352
Authors: Giju Thomas; Melanie A McWade; Constantine Paras; Emmanuel A Mannoh; Melinda E Sanders; Lisa M White; James T Broome; John E Phay; Naira Baregamian; Carmen C Solórzano; Anita Mahadevan-Jansen Journal: Thyroid Date: 2018-09-11 Impact factor: 6.568